"At Baptist Health in Jacksonville, FL, our mission is to continue the healing ministry of Christ by providing accessible, quality health care services at a reasonable cost in an atmosphere that fosters respect and compassion."

During the past decade, Lyerly Neurosurgery conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lyerly Neurosurgery" #1 sponsor was "NuVasive" with 3 trials, followed by "Microvention-Terumo, Inc." with 2 trials sponsored, "Alphatec Spine, Inc." with 1 trials sponsored, "Cerebrotech Medical Systems, Inc." with 1 trials sponsored and "Northwestern University" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lyerly Neurosurgery" #1 collaborator was "MicroVention, Inc." with 1 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Lyerly Neurosurgery" are "Degenerative Disc Disease" (3 trials), "Degenerative Scoliosis" (2 trials), "Intracranial Aneurysms" (2 trials), "Spondylolisthesis" (2 trials) and "Carotid Stenosis" (1 trials). Many other conditions were trialed in "Lyerly Neurosurgery" in a lesser frequency.

Most popular intervention types in "Lyerly Neurosurgery" are "Device" (6 trials), "Diagnostic Test" (1 trials), "Drug" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carotid Stenting (CAS)" (1 trials), "Carotid endarterectomy (CEA)" (1 trials), "Control (bare platinum coils)" (1 trials), "Flow Re-Direction Endoluminal Device (FRED)" (1 trials) and "HydroCoil Embolic System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lyerly Neurosurgery" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Lyerly Neurosurgery". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 5 completed trials in Lyerly Neurosurgery, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lyerly Neurosurgery, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".